Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04887441
Other study ID # RECHMPL21_0253
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date September 1, 2019
Est. completion date October 1, 2022

Study information

Verified date May 2021
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Digital technology is essential in the field of health, via connected objects, the medical Internet or even telemedicine; and the info-communication practices (ways of getting information and communicating) of the actors go through digital devices. In addition, at present, the mass of activity documents to be managed in healthcare establishments and an abundant supply of documentary resources in health, available on the Internet, lead to infobesity, information pollution, and work overload. These phenomena lead to an increase in the time spent searching for relevant information and even to the burnout of healthcare professionals. A contextualization of the information communication systems through which the practices of health professionals pass therefore seems necessary so that the tools for managing, extracting and organizing knowledge can support these actors in their work. In the field of allergies, there are many players, and the information that is useful to them is abundant and heterogeneous. This study is based on the hypothesis that a knowledge organization model, developed from existing practices, could make it possible to obtain satisfactory results when searching for information, and be integrated into the daily practices of actors by linking up with other already existing systems and tools.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 2000
Est. completion date October 1, 2022
Est. primary completion date October 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion criteria: - Professionals from the Allergy Unit (doctors, interns, paramedics, study coordinators), in total around 20-30 people. - Observations will be conducted during their team meetings and will not impact their workflow. - Subjects publishing information on allergy on public web sites Exclusion criteria: - Professional not willing to participate to the research. - Users publishing information on private web sites or forums.

Study Design


Locations

Country Name City State
France Uhmontpellier Montpellier

Sponsors (3)

Lead Sponsor Collaborator
University Hospital, Montpellier LERASS-CERIC Université Paul Valéry Montpellier 3 Motpellier, Occitanie Region

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the ontology model measure (a) the efficiency of the model developed in the target technology (technology-focused evaluation), (b) the satisfaction of the professionals of the unit (user-focused evaluation) and (c) we will evaluate its formalization by an expert in knowledge organization systems (ontology-focused evaluation). The evaluations (a) and (b) will be made through the integration of the model into a future information communication device, and probably, into another existing device. The task will consist, for example, in the search for information and documents necessary for the information activities of professionals. 24 months
Secondary Assessment and validation of the model (a) At the end of the interrogation of a tool designed by professionals, we will calculate the recall rate, precision and F-measure. The efficiency of the model will be considered satisfactory, if the result obtained is equal or superior to other projects (b) The organizational model assessment will engage 10 professionals from the allergology unit. Professionals will assign (anonymously) the marks according to the level of satisfaction of the results of their request: 5 - Very satisfactory, 4 - Satisfactory, 3 - Fairly satisfactory, 2 - Unsatisfactory, 1 - Unsatisfactory. (c) The model will also be evaluated by a knowledge organization systems expert, selected from members of the International Society for Knowledge Organization. 18 months
See also
  Status Clinical Trial Phase
Withdrawn NCT03089476 - Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy N/A
Recruiting NCT05839405 - Food Allergy in the Brain
Completed NCT02552537 - iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions Phase 4
Completed NCT01634737 - Crustacean Allergy and Dust Mites Sensitization N/A
Completed NCT05072665 - Fast Allergy Sensitivity Test N/A
Recruiting NCT03265262 - The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy N/A
Completed NCT04186949 - Early Origins of Allergy and Asthma
Completed NCT02490007 - Pertussis Immunisation and Food Allergy
Recruiting NCT03151252 - Improvement of Foodallergy Diagnostic in Gastrointestinal Tract N/A
Completed NCT02159833 - Intranasal Diagnostics in Food Allergy: a Feasibility Study N/A
Completed NCT02377284 - Prevention and Management of Food Allergies N/A
Completed NCT02354729 - Encouraging Allergic Young Adults to Carry Epinephrine N/A
Completed NCT02640560 - One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish N/A
Enrolling by invitation NCT06097572 - Improved Diagnostics in Food Allergy Study N/A
Recruiting NCT04606615 - Skin Barrier Abnormalities and Oxidative Stress Response
Recruiting NCT05785299 - Clinical Versus Home Introduction of Milk in Children With Non-IgE-mediated Cow's Milk Allergy N/A
Not yet recruiting NCT06112873 - Quality of Life in Food Allergy: Validation of Three Mini-questionnaires
Completed NCT03337802 - Effect of Mediterranean Diet During Pregnancy on the Onset of Overweight and Obesity in the Offspring N/A
Not yet recruiting NCT06085118 - Observatory on Cow's Milk Protein Allergy
Completed NCT02223182 - Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy Phase 1/Phase 2